333 related articles for article (PubMed ID: 15042326)
1. Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities?
Valdés Olmos RA; Hoefnagel CA
Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):929-31. PubMed ID: 15042326
[No Abstract] [Full Text] [Related]
2. Radionuclide therapy in oncology: repeated administrations of high dose rate radiopharmaceuticals.
Palmedo H; Bucerius J
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1556. PubMed ID: 15372210
[No Abstract] [Full Text] [Related]
3. Systemic targeted radionuclide therapy: potential new areas.
Wong JY
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S74-82. PubMed ID: 16979445
[TBL] [Abstract][Full Text] [Related]
4. New Developments in Radiation Oncology.
Michalski JM
Mo Med; 2015; 112(5):354. PubMed ID: 26606814
[No Abstract] [Full Text] [Related]
5. A pragmatic perspective on molecular targeted radionuclide therapy.
Larson SM; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():1S-3S. PubMed ID: 15653645
[No Abstract] [Full Text] [Related]
6. Advances in radiation therapy.
Forstner DF; Yap ML
Med J Aust; 2015 Nov; 203(10):394-5. PubMed ID: 26561898
[No Abstract] [Full Text] [Related]
7. Testicular cancer: a reflection on 50 years of discovery.
Hanna N; Einhorn LH
J Clin Oncol; 2014 Oct; 32(28):3085-92. PubMed ID: 25024068
[No Abstract] [Full Text] [Related]
8. Medical management of brain metastases.
Butowski N
Neurosurg Clin N Am; 2011 Jan; 22(1):27-36, v-vi. PubMed ID: 21109146
[TBL] [Abstract][Full Text] [Related]
9. [Demand for proton-ray therapy in Russia by 2010].
Khmelevskiĭ EV
Vopr Onkol; 2009; 55(4):430-2. PubMed ID: 19947364
[No Abstract] [Full Text] [Related]
10. Defining a future role for radiogenic therapy.
Kaminski JM; Kaminski RJ; Dicker AP; Urbain JL
Cancer Treat Rev; 2001 Oct; 27(5):289-94. PubMed ID: 11871865
[TBL] [Abstract][Full Text] [Related]
11. Targeted α-Therapy.
Brechbiel MW
Cancer Biother Radiopharm; 2020 Aug; 35(6):397. PubMed ID: 32503377
[No Abstract] [Full Text] [Related]
12. [Innovation in radiotherapy in 2021].
Masson I; Dutreix M; Supiot S
Bull Cancer; 2021 Jan; 108(1):42-49. PubMed ID: 33303195
[No Abstract] [Full Text] [Related]
13. Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology.
Bentzen SM
Cancer Treat Res; 2008; 139():41-62. PubMed ID: 18236711
[No Abstract] [Full Text] [Related]
14. Development of computer systems for radiotherapy of cancer.
Umegaki Y
Jpn J Clin Oncol; 2010 Sep; 40(9):e65-82. PubMed ID: 20736216
[No Abstract] [Full Text] [Related]
15. Nuclear localizing sequences: an innovative way to improve targeted radiotherapy.
O'Donnell RT
J Nucl Med; 2006 May; 47(5):738-9. PubMed ID: 16644741
[No Abstract] [Full Text] [Related]
16. The present and future of radiation oncology in Spain.
Guedea F
Clin Transl Oncol; 2011 Sep; 13(9):697-9. PubMed ID: 21865143
[No Abstract] [Full Text] [Related]
17. Clinical Radioimmunotherapy and Systemic Targeted Radiopharmaceutical Therapy (STaRT) programs in a radiation oncology environment.
Macklis RM
Am J Clin Oncol; 2006 Dec; 29(6):543-7. PubMed ID: 17148988
[No Abstract] [Full Text] [Related]
18. Three discipline collaborative radiation therapy (3DCRT) special debate: Equipment development is stifling innovation in radiation oncology.
Kim L; Markovina S; Van Nest SJ; Eisaman S; Santanam L; Sullivan JM; Dominello M; Joiner MC; Burmeister J
J Appl Clin Med Phys; 2019 Sep; 20(9):6-11. PubMed ID: 31127693
[No Abstract] [Full Text] [Related]
19. Carbon ion therapy to debut in Europe.
Brower V
J Natl Cancer Inst; 2009 Jan; 101(2):74-6. PubMed ID: 19141776
[No Abstract] [Full Text] [Related]
20. Antibody-based cancer therapies: back to "polyclonals"?
Paganelli G; De Santis R
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1453-5. PubMed ID: 15258701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
